Drug Type Small molecule drug |
Synonyms R481 |
Target |
Mechanism AMPK agonists(AMP activated protein kinase agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H33F3N4O3 |
InChIKeyLKEAXBYFCTZTLD-UHFFFAOYSA-N |
CAS Registry1152423-98-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypoglycemia | Preclinical | US | 17 Dec 2021 |